CDNA
Get informed when a big investor buys or sells
+ FollowOvervalued by 103.9% based on the discounted cash flow analysis.
| Market cap | $2.51 Billion |
|---|---|
| Enterprise Value | $2.15 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.4 |
| Beta | 2.42 |
| Outstanding Shares | 51,469,375 |
| P/E Ratio | 22.59 |
|---|---|
| PEG | -1.62 |
| Price to Sales | 5.77 |
| Price to Book Ratio | 5.77 |
| Enterprise Value to Revenue | 4.7 |
| Enterprise Value to EBIT | 19.41 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 55,200▲ 171.92% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 104.09%▲ 1.33% |
|---|---|
| Total Invested | $1.52B▲ 66.13% |
| Investors Holding | 229▲ 39.00% |
No data